Zheng Feng, Di Shao, Yuhang Cai, Rui Bi, Xingzhu Ju, Dongju Chen, . . . Hao Wen. (2023). Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma. BMC.
Chicago Style (17th ed.) CitationZheng Feng, et al. Homologous Recombination Deficiency Status Predicts Response to Platinum-based Chemotherapy in Chinese Patients with High-grade Serous Ovarian Carcinoma. BMC, 2023.
MLA (9th ed.) CitationZheng Feng, et al. Homologous Recombination Deficiency Status Predicts Response to Platinum-based Chemotherapy in Chinese Patients with High-grade Serous Ovarian Carcinoma. BMC, 2023.
Warning: These citations may not always be 100% accurate.